e-learning
resources
European Respiratory Review
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multidrug- and extensively drug-resistant tuberculosis: an emerging threat
Berry M., Kon O. M.
Source:
Eur Respir Rev 2009; 18: 195-197
Journal Issue:
December 2009 - 18 (114)
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Berry M., Kon O. M.. Multidrug- and extensively drug-resistant tuberculosis: an emerging threat. Eur Respir Rev 2009; 18: 195-197
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Source: Eur Respir J 2016; 47: 564-574
Year: 2016
Extensively drug-resistant tuberculosis: back to the future
Source: Eur Respir J 2010; 36: 475-477
Year: 2010
Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?
Source: Eur Respir J, 55 (2) 1901908; 10.1183/13993003.01908-2019
Year: 2020
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and treatment
Source: Annual Congress 2008 - Infection year in review
Year: 2008
Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR)
mycobacterium tuberculosis
strains in clinical practice
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis
Source: Annual Congress 2009 - Priorities in tuberculosis research
Year: 2009
Treating extensively drug resistant tuberculosis (XDR-TB) in India
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009–2016
Source: Eur Respir J, 52 (1) 1800070; 10.1183/13993003.00070-2018
Year: 2018
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
Source: Eur Respir J 2008; 31: 1155-1159
Year: 2008
Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis
Source: Eur Respir J, 54 (1) 1802208; 10.1183/13993003.02208-2018
Year: 2019
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 872-873
Year: 2013
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 870-872
Year: 2013
Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
A new era for treatment of drug-resistant tuberculosis
Source: Eur Respir J, 52 (4) 1801350; 10.1183/13993003.01350-2018
Year: 2018
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
Source: Eur Respir J 2012; 39: 956-962
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept